Joshua H. Bilenker, President & CEO at Loxo Oncology, Inc. (LOXO), sold 6,800 shares at $133.11 ($936K) on 2018-05-15, disclosed to the SEC on 2018-05-16.
Open-market sale of $936k LOXO by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $133.11 | 700 | $93K | 10.0% |
| 2 | $135.83 | 1,000 | $136K | 14.5% |
| 3 | $138.35 | 3,297 | $456K | 48.8% |
| 4 | $138.89 | 1,803 | $250K | 26.8% |
| Total | $137.58 avg | 6,800 | $936K | 100% |
| Filing → |
| LOXO | SELL | 2018-12-12 | $2.7M | — | Filing → |
| LOXO | SELL | 2018-12-12 | $1.0M | — | Filing → |
| LOXO | SELL | 2018-11-28 | $1.2M | — | Filing → |